ISTI LOGO
Towards a new dawn
×

img Acces sibility Controls

Technologies Banner

All Technologies

BBV154 - A novel adenovirus vectored, intranasal vaccine for COVID-19

Implementing Organization

Project Overview

DBT-BIRAC supported India's first Intranasal vaccine to prevent COVID-19 by Bharat Biotech private limited

Related Research

View All
Funding Organization
Funding Organization

—

Quick Information
Focus Area
Vaccines, Infectious Diseases
Status
Market authorization is received for COVID 19
Output
No. of Research Paper
00
Technologies (If Any)
00
No. of PhD Produced
N/A
Startup (If Any)
00
No. of Patents
Filed :00
Grant :00
arrowtop